BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNanoâ„¢. RenNanoâ„¢ is the ...
VITT antibodies feature an oligoclonal or monoclonal antibody profile with a remarkable degree of clonal identity of the light chains, 3,4 which results in a strikingly similar structure of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results